Rousou Anthony J, Ericsson Maria, Federman Micheline, Levitsky Sidney, McCully James D
Div. of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 77 Ave. Louis Pasteur, Rm. 144, Boston, MA 02115, USA.
Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H1967-76. doi: 10.1152/ajpheart.00338.2004. Epub 2004 Jul 8.
Previously, we have shown that the pharmacological opening of the mitochondrial ATP-sensitive K channels with diazoxide (DZX) enhances the cardioprotection afforded by magnesium-supplemented potassium (K/Mg) cardioplegia. To determine the mechanisms involved in the cardioprotection afforded by K/Mg + DZX cardioplegia, rabbit hearts (n=24) were subjected to isolated Langendorff perfusion. Control hearts were perfused for 75 min. Global ischemia (GI) hearts were subjected to 30 min of equilibrium, 30 min of GI, and 15 min of reperfusion. K/Mg and K/Mg + DZX cardioplegia hearts received either K/Mg or K/Mg + DZX for 5 min before GI and reperfusion. Tissue was harvested for mitochondrial isolation and transmission electron microscopy (TEM). Mitochondrial structure, area, matrix volume, free calcium, and oxygen consumption were determined. TEM demonstrated that GI mitochondria were damaged and that K/Mg and K/Mg + DZX preserved mitochondrial structure. TEM and light scattering demonstrated separately that mitochondrial matrix and cristae area and matrix volume were significantly increased after GI and reperfusion with GI > K/Mg + DZX > K/Mg hearts (P <0.05 vs. control). Mitochondrial free calcium was significantly increased in GI and K/Mg hearts. K/Mg + DZX significantly decreased mitochondrial free calcium accumulation (P <0.05 vs. GI and K/Mg). State 3 oxygen consumption and respiratory control index in malate (complex I substrate)- and succinate (complex II substrate)-energized mitochondria were significantly decreased (P <0.05 vs. control) in the GI and K/Mg + DZX groups. These data indicate that the enhanced cardioprotection afforded by K/Mg + DZX cardioplegia occurs through the preservation of mitochondrial structure and the significant decrease in mitochondrial free calcium accumulation and mitochondrial state 3 oxygen consumption.
此前,我们已经表明,用二氮嗪(DZX)使线粒体ATP敏感性钾通道药理学开放可增强补充镁的钾(K/Mg)心脏停搏液所提供的心脏保护作用。为了确定K/Mg + DZX心脏停搏液所提供的心脏保护作用的机制,对24只兔心脏进行离体Langendorff灌注。对照心脏灌注75分钟。全心缺血(GI)心脏经历30分钟平衡期、30分钟全心缺血和15分钟再灌注。K/Mg和K/Mg + DZX心脏停搏液组的心脏在全心缺血和再灌注前分别接受K/Mg或K/Mg + DZX灌注5分钟。采集组织用于线粒体分离和透射电子显微镜(TEM)检查。测定线粒体结构、面积、基质体积、游离钙和氧消耗。透射电子显微镜显示全心缺血线粒体受损,而K/Mg和K/Mg + DZX可保留线粒体结构。透射电子显微镜和光散射分别显示,全心缺血和再灌注后,线粒体基质和嵴面积以及基质体积显著增加,且全心缺血组 > K/Mg + DZX组 > K/Mg组心脏(与对照组相比,P <0.05)。全心缺血和K/Mg组心脏线粒体游离钙显著增加。K/Mg + DZX显著降低线粒体游离钙蓄积(与全心缺血和K/Mg组相比,P <0.05)。在苹果酸(复合体I底物)和琥珀酸(复合体II底物)供能的线粒体中,全心缺血组和K/Mg + DZX组的状态3氧消耗和呼吸控制指数显著降低(与对照组相比,P <0.05)。这些数据表明,K/Mg + DZX心脏停搏液所提供的增强的心脏保护作用是通过保留线粒体结构以及显著降低线粒体游离钙蓄积和线粒体状态3氧消耗来实现的。